Cordycepin enhances cisplatin apoptotic effect through caspase/MAPK pathways in human head and neck tumor cells

Ying Hui Chen, Jo Yu Wang, Bo Syong Pan, Yi Fen Mu, Meng Shao Lai, Edmund Cheung So, Thian Sze Wong, Bu-Miin Huang

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose: The present study aims to investigate whether the combination treatment of cordycepin (an extracted pure compound from Cordyceps sinensis) and cisplatin (a platinumbased chemotherapy drug) has better apoptotic effect in head and neck squamous cell carcinoma (HNSCC). Methods: The apoptotic influences of cordycepin and/or cisplatin treatments to human OC3, OEC-M1, and FaDu HNSCC cells were investigated by morphological observations, viability assay, flow cytometry assay, and Western blotting methods. Results: Data showed that the cell death phenomenon increased as the dosage of cordycepin or cisplatin increased, and it appeared more in cordycepin plus cisplatin cotreatment among three cell lines. Cell survival rates significantly decreased as the dosage of cordycepin or cisplatin increased, and the better apoptotic effects were observed in cotreatment. Cell cycle analysis further demonstrated that percentages of subG1 cells in cordycepin or cisplatin treatments significantly increased, suggesting that cells underwent apoptosis, and cordycepin plus cisplatin induced many more subG1 cells. Furthermore, cordycepin or cisplatin induced caspase-8, caspase-9, caspase-3, and poly adenosine diphosphate-ribose polymerase protein cleavages, and stimulated c-Jun NH2-terminal kinase, extracellular signal-regulated kinase, and p38 protein phosphorylations. Moreover, cordycepin plus cisplatin cotreatment significantly activated those proteins with much better effects among three cell lines. Conclusion: Cordycepin plus cisplatin have better apoptotic effect by activating caspase activation with possible MAPK pathway involvement in HNSCC cells.

Original languageEnglish
Pages (from-to)983-998
Number of pages16
JournalOncoTargets and Therapy
Volume6
DOIs
Publication statusPublished - 2013 Aug 7

Fingerprint

Caspases
Cisplatin
Neck
Head
Neoplasms
Cordyceps
cordycepin
Poly Adenosine Diphosphate Ribose
Cell Line
Proteins
Caspase 9
Caspase 8
JNK Mitogen-Activated Protein Kinases
Extracellular Signal-Regulated MAP Kinases
Caspase 3
Cell Survival
Cell Cycle
Flow Cytometry
Cell Death
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pharmacology (medical)

Cite this

Chen, Ying Hui ; Wang, Jo Yu ; Pan, Bo Syong ; Mu, Yi Fen ; Lai, Meng Shao ; So, Edmund Cheung ; Wong, Thian Sze ; Huang, Bu-Miin. / Cordycepin enhances cisplatin apoptotic effect through caspase/MAPK pathways in human head and neck tumor cells. In: OncoTargets and Therapy. 2013 ; Vol. 6. pp. 983-998.
@article{c2d7b76b464d4ec0a1bb5877db50e91b,
title = "Cordycepin enhances cisplatin apoptotic effect through caspase/MAPK pathways in human head and neck tumor cells",
abstract = "Purpose: The present study aims to investigate whether the combination treatment of cordycepin (an extracted pure compound from Cordyceps sinensis) and cisplatin (a platinumbased chemotherapy drug) has better apoptotic effect in head and neck squamous cell carcinoma (HNSCC). Methods: The apoptotic influences of cordycepin and/or cisplatin treatments to human OC3, OEC-M1, and FaDu HNSCC cells were investigated by morphological observations, viability assay, flow cytometry assay, and Western blotting methods. Results: Data showed that the cell death phenomenon increased as the dosage of cordycepin or cisplatin increased, and it appeared more in cordycepin plus cisplatin cotreatment among three cell lines. Cell survival rates significantly decreased as the dosage of cordycepin or cisplatin increased, and the better apoptotic effects were observed in cotreatment. Cell cycle analysis further demonstrated that percentages of subG1 cells in cordycepin or cisplatin treatments significantly increased, suggesting that cells underwent apoptosis, and cordycepin plus cisplatin induced many more subG1 cells. Furthermore, cordycepin or cisplatin induced caspase-8, caspase-9, caspase-3, and poly adenosine diphosphate-ribose polymerase protein cleavages, and stimulated c-Jun NH2-terminal kinase, extracellular signal-regulated kinase, and p38 protein phosphorylations. Moreover, cordycepin plus cisplatin cotreatment significantly activated those proteins with much better effects among three cell lines. Conclusion: Cordycepin plus cisplatin have better apoptotic effect by activating caspase activation with possible MAPK pathway involvement in HNSCC cells.",
author = "Chen, {Ying Hui} and Wang, {Jo Yu} and Pan, {Bo Syong} and Mu, {Yi Fen} and Lai, {Meng Shao} and So, {Edmund Cheung} and Wong, {Thian Sze} and Bu-Miin Huang",
year = "2013",
month = "8",
day = "7",
doi = "10.2147/OTT.S45322",
language = "English",
volume = "6",
pages = "983--998",
journal = "OncoTargets and Therapy",
issn = "1178-6930",
publisher = "Dove Medical Press Ltd.",

}

Cordycepin enhances cisplatin apoptotic effect through caspase/MAPK pathways in human head and neck tumor cells. / Chen, Ying Hui; Wang, Jo Yu; Pan, Bo Syong; Mu, Yi Fen; Lai, Meng Shao; So, Edmund Cheung; Wong, Thian Sze; Huang, Bu-Miin.

In: OncoTargets and Therapy, Vol. 6, 07.08.2013, p. 983-998.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cordycepin enhances cisplatin apoptotic effect through caspase/MAPK pathways in human head and neck tumor cells

AU - Chen, Ying Hui

AU - Wang, Jo Yu

AU - Pan, Bo Syong

AU - Mu, Yi Fen

AU - Lai, Meng Shao

AU - So, Edmund Cheung

AU - Wong, Thian Sze

AU - Huang, Bu-Miin

PY - 2013/8/7

Y1 - 2013/8/7

N2 - Purpose: The present study aims to investigate whether the combination treatment of cordycepin (an extracted pure compound from Cordyceps sinensis) and cisplatin (a platinumbased chemotherapy drug) has better apoptotic effect in head and neck squamous cell carcinoma (HNSCC). Methods: The apoptotic influences of cordycepin and/or cisplatin treatments to human OC3, OEC-M1, and FaDu HNSCC cells were investigated by morphological observations, viability assay, flow cytometry assay, and Western blotting methods. Results: Data showed that the cell death phenomenon increased as the dosage of cordycepin or cisplatin increased, and it appeared more in cordycepin plus cisplatin cotreatment among three cell lines. Cell survival rates significantly decreased as the dosage of cordycepin or cisplatin increased, and the better apoptotic effects were observed in cotreatment. Cell cycle analysis further demonstrated that percentages of subG1 cells in cordycepin or cisplatin treatments significantly increased, suggesting that cells underwent apoptosis, and cordycepin plus cisplatin induced many more subG1 cells. Furthermore, cordycepin or cisplatin induced caspase-8, caspase-9, caspase-3, and poly adenosine diphosphate-ribose polymerase protein cleavages, and stimulated c-Jun NH2-terminal kinase, extracellular signal-regulated kinase, and p38 protein phosphorylations. Moreover, cordycepin plus cisplatin cotreatment significantly activated those proteins with much better effects among three cell lines. Conclusion: Cordycepin plus cisplatin have better apoptotic effect by activating caspase activation with possible MAPK pathway involvement in HNSCC cells.

AB - Purpose: The present study aims to investigate whether the combination treatment of cordycepin (an extracted pure compound from Cordyceps sinensis) and cisplatin (a platinumbased chemotherapy drug) has better apoptotic effect in head and neck squamous cell carcinoma (HNSCC). Methods: The apoptotic influences of cordycepin and/or cisplatin treatments to human OC3, OEC-M1, and FaDu HNSCC cells were investigated by morphological observations, viability assay, flow cytometry assay, and Western blotting methods. Results: Data showed that the cell death phenomenon increased as the dosage of cordycepin or cisplatin increased, and it appeared more in cordycepin plus cisplatin cotreatment among three cell lines. Cell survival rates significantly decreased as the dosage of cordycepin or cisplatin increased, and the better apoptotic effects were observed in cotreatment. Cell cycle analysis further demonstrated that percentages of subG1 cells in cordycepin or cisplatin treatments significantly increased, suggesting that cells underwent apoptosis, and cordycepin plus cisplatin induced many more subG1 cells. Furthermore, cordycepin or cisplatin induced caspase-8, caspase-9, caspase-3, and poly adenosine diphosphate-ribose polymerase protein cleavages, and stimulated c-Jun NH2-terminal kinase, extracellular signal-regulated kinase, and p38 protein phosphorylations. Moreover, cordycepin plus cisplatin cotreatment significantly activated those proteins with much better effects among three cell lines. Conclusion: Cordycepin plus cisplatin have better apoptotic effect by activating caspase activation with possible MAPK pathway involvement in HNSCC cells.

UR - http://www.scopus.com/inward/record.url?scp=84880988391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880988391&partnerID=8YFLogxK

U2 - 10.2147/OTT.S45322

DO - 10.2147/OTT.S45322

M3 - Article

VL - 6

SP - 983

EP - 998

JO - OncoTargets and Therapy

JF - OncoTargets and Therapy

SN - 1178-6930

ER -